<?xml version="1.0" encoding="UTF-8"?>
<document>
<type>mainstream</type>
<forum></forum>
<forum_title></forum_title>
<discussion_title>Granules India Q1 Net Up 37% At Rs 39 Crore â€“ NDTV Profit</discussion_title>
<language>english</language>
<gmt_offset></gmt_offset>
<topic_url>http://profit.ndtv.com/news/earnings/article-granules-india-q1-net-up-37-at-rs-39-crore-1443336</topic_url>
<topic_text>
Press Trust of India | Last Updated: August 12, 2016 11:14 (IST) EMAIL COMMENTS New Delhi: Drug firm Granules India on Thursday reported 36.55 per cent rise in consolidated net profit at Rs 38.96 crore for the quarter ended June 30.The company had posted a net profit after taxes and share of profit/(loss) of the associates of Rs 28.53 crore for the same period a year ago, Granules India said in a filing to BSE.Consolidated total income from operations also rose to Rs 343.73 crore for the quarter under review as against Rs 322.56 crore in the year-ago period.&quot;Our top-line growth was slightly subdued but we have once again demonstrated our strength in operational excellence with improved bottom line,&quot; Granules India Chairman &amp; MD Krishna Prasad Chigurupati said.In a separate filing, Granules India said its board has approved interim dividend of 20 paise per share of face value of Re 1 each. (This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.) Story first published on : August 12, 2016 11:14 (IST) Trending 
</topic_text>
<spam_score>0.50</spam_score>
<post_num>1</post_num>
<post_id>post-1</post_id>
<post_url>http://profit.ndtv.com/news/earnings/article-granules-india-q1-net-up-37-at-rs-39-crore-1443336</post_url>
<post_date>20160612</post_date>
<post_time></post_time>
<username></username>
<post>
Press Trust of India | Last Updated: August 12, 2016 11:14 (IST) EMAIL COMMENTS New Delhi: Drug firm Granules India on Thursday reported 36.55 per cent rise in consolidated net profit at Rs 38.96 crore for the quarter ended June 30.The company had posted a net profit after taxes and share of profit/(loss) of the associates of Rs 28.53 crore for the same period a year ago, Granules India said in a filing to BSE.Consolidated total income from operations also rose to Rs 343.73 crore for the quarter under review as against Rs 322.56 crore in the year-ago period.&quot;Our top-line growth was slightly subdued but we have once again demonstrated our strength in operational excellence with improved bottom line,&quot; Granules India Chairman &amp; MD Krishna Prasad Chigurupati said.In a separate filing, Granules India said its board has approved interim dividend of 20 paise per share of face value of Re 1 each. (This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.) Story first published on : August 12, 2016 11:14 (IST) Trending 
</post>
<signature>

</signature>
<external_links>

</external_links>
<country>US</country>
<main_image>http://i.ndtvimg.com/i/2016-06/medicine-pharma-drug-625-300_625x300_61465225576.jpg</main_image>
</document>
